Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgenic mouse models for myotonic dystrophy type 1 (DM1).

D G Wansink1, B Wieringa

  • 1Department of Cell Biology, NCMLS, University Medical Center, Nijmegen, The Netherlands.

Cytogenetic and Genome Research
|October 4, 2003
PubMed
Summary

Animal models reveal how repeat expansions in myotonic dystrophy type 1 (DM1) cause multisystemic disease. DNA repair and toxic RNA gain-of-function mechanisms are key to DM1 pathology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disturbed energy metabolism and muscular dystrophy caused by pure creatine deficiency are reversible by creatine intake.

The Journal of physiology·2012
Same author

Letter to the editor: "Interpretation of (31)P NMR saturation transfer experiments: do not forget the spin relaxation properties".

American journal of physiology. Cell physiology·2012
Same author

Myotonic dystrophy type 2 (DM2) and related disorders report of the 180th ENMC workshop including guidelines on diagnostics and management 3-5 December 2010, Naarden, The Netherlands.

Neuromuscular disorders : NMD·2011
Same author

Advantages of indium-tin oxide-coated glass slides in correlative scanning electron microscopy applications of uncoated cultured cells.

Journal of microscopy·2009
Same author

Activation of glucose transport and AMP-activated protein kinase during muscle contraction in adenylate kinase-1 knockout mice.

Acta physiologica (Oxford, England)·2007
Same author

An adenylate kinase is involved in KATP channel regulation of mouse pancreatic beta cells.

Diabetologia·2007

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Myotonic dystrophy type 1 (DM1) presents with variable multisystemic features.
  • The disease is linked to the expansion of a CTG repeat in the DM1 locus.
  • Understanding the genetic and molecular basis of DM1 is crucial for developing effective therapies.

Purpose of the Study:

  • To review new insights into the pathobiology of DM1.
  • To explore the role of DNA replication/repair/recombination machinery in repeat instability.
  • To discuss the gain-of-function mechanism involving toxic RNA transcripts and potential loss-of-function genes.

Main Methods:

  • Review of existing literature and studies on animal models of DM1.
  • Analysis of DNA and RNA mechanisms contributing to DM1.
  • Comparative study of DM1 and DM2 pathobiology.

Main Results:

  • Evidence suggests cell type, state, and species-specific DNA machinery activities influence repeat behavior.
  • A gain-of-function mechanism involving toxic CUG repeat transcripts plays a central role in DM1.
  • DM2 studies highlight potential loss-of-function genes contributing to DM1-unique clinical aspects.

Conclusions:

  • Animal models have been instrumental in dissecting DM1 pathobiology.
  • Both repeat expansion instability and toxic RNA gain-of-function are critical.
  • Further research into candidate loss-of-function genes may explain DM1-specific phenotypes.

Related Experiment Videos